Alyeska Investment Group
CFRX

Alyeska Investment Group’s ContraFect Corporation CFRX Stock Holding History

Alyeska Investment Group’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,625
Closed -$6M – 1041
2021
Q1 		$6M Buy
+15,625
New +$6.74M 0.08% 296
2020
Q3 		– Sell
-24,375
Closed -$12.5M – 665
2020
Q2 		$12.5M Buy
24,375
+937
+4% +$460K 0.19% 170
2020
Q1 		$10.8M Buy
23,438
+21,094
+900% +$14.4M 0.22% 124
2019
Q4 		$1.16M Hold
2,344
– – 0.02% 321
2019
Q3 		$672K Hold
2,344
– – 0.01% 344
2019
Q2 		$957K Hold
2,344
– – 0.01% 367
2019
Q1 		$746K Hold
2,344
– – 0.01% 330
2018
Q4 		$2.87M Hold
2,344
– – 0.04% 263
2018
Q3 		$3.88M Hold
2,344
– – 0.04% 260
2018
Q2 		$4.14M Hold
2,344
– – 0.04% 288
2018
Q1 		$3.05M Hold
2,344
– – 0.03% 322
2017
Q4 		$1.89M Hold
2,344
– – 0.02% 344
2017
Q3 		$2.08M Buy
2,344
+781
+50% +$738K 0.02% 359
2017
Q2 		$1.81M Hold
1,563
– – 0.02% 357
2017
Q1 		$2.25M Hold
1,563
– – 0.02% 390
2016
Q4 		$2.19M Hold
1,563
– – 0.02% 385
2016
Q3 		$3.1M Buy
+1,563
New +$3.07M 0.03% 362

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group's CFRX Position: Q3 2021 in Review

Alyeska Investment Group sold out of ContraFect Corporation (CFRX) in Q3 2021, closing a stake of 3,125 shares — an estimated $1.1M sold.

Alyeska Investment Group first reported a position in CFRX in Q3 2016 and held it in 8 quarters. The position peaked at $2.17M in Q3 2016. 56 funds tracked by Wall St. Rank hold CFRX as of Q3 2021.

  • Alyeska Investment Group reported no remaining ContraFect Corporation position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 3,125 ContraFect Corporation shares in Q3 2021, an estimated $1.1M.
  • Alyeska Investment Group first reported a position in ContraFect Corporation in Q3 2016 and held it in 8 quarters.
  • Alyeska Investment Group's ContraFect Corporation position peaked at $2.17M in Q3 2016.
  • 56 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.